Sysmex ADR Total Long Term Liabilities 2016-2024 | SSMXY
Sysmex ADR total long term liabilities from 2016 to 2024. Total long term liabilities can be defined as the sum of all non-current liabilities.
- Sysmex ADR total long term liabilities for the quarter ending December 31, 2024 were $0.458B, a 89.5% increase year-over-year.
- Sysmex ADR total long term liabilities for 2024 were $0.45B, a 92.32% increase from 2023.
- Sysmex ADR total long term liabilities for 2023 were $0.234B, a 19.29% decline from 2022.
- Sysmex ADR total long term liabilities for 2022 were $0.29B, a 11.35% increase from 2021.
| Sysmex ADR Annual Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024 | $450 |
| 2023 | $234 |
| 2022 | $290 |
| 2021 | $260 |
| 2020 | $246 |
| 2019 | $93 |
| 2018 | $92 |
| 2017 | $86 |
| 2016 | $121 |
| Sysmex ADR Quarterly Total Long Term Liabilities (Millions of US $) |
|
|---|---|
| 2024-06-30 | $458 |
| 2023-06-30 | $262 |
| 2022-06-30 | $258 |
| 2021-06-30 | $269 |
| 2020-06-30 | $242 |
| 2019-06-30 | $243 |
| 2018-06-30 | $88 |
| 2017-06-30 | $88 |
| 2016-06-30 | $114 |
| 2016-03-31 | $121 |
| 2015-12-31 | |
| 2015-09-30 | |
| 2015-06-30 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $10.571B | $3.340B |
| Sysmex Corporation is engaged in the development, manufacture, import, export and sale of clinical laboratory instruments, reagents and software used in -vitro diagnostics. It also provides clinical laboratory testing of blood, urine and other specimens. The company's product includes instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis and point-of-care testing. Its operating segment consists of Japan, Americas, EMEA, China and Asia Pacific. Sysmex Corporation is headquartered in Kobe, Japan. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $199.696B | 87.47 |
| Thermo Fisher Scientific (TMO) | United States | $156.188B | 18.89 |
| Edwards Lifesciences (EW) | United States | $45.655B | 29.93 |
| Alcon (ALC) | Switzerland | $43.440B | 29.36 |
| IDEXX Laboratories (IDXX) | United States | $41.591B | 47.80 |
| DexCom (DXCM) | United States | $34.247B | 52.93 |
| IQVIA Holdings (IQV) | United States | $25.076B | 14.05 |
| Mettler-Toledo (MTD) | United States | $24.648B | 29.31 |
| STERIS (STE) | Ireland | $24.609B | 27.14 |
| Waters (WAT) | United States | $21.548B | 30.40 |
| SONOVA HOLDING (SONVY) | Switzerland | $20.213B | 0.00 |
| Hologic (HOLX) | United States | $12.584B | 13.67 |
| Penumbra (PEN) | United States | $10.887B | 85.45 |
| Globus Medical (GMED) | United States | $8.473B | 19.87 |
| Masimo (MASI) | United States | $8.467B | 31.23 |
| Teleflex (TFX) | United States | $5.606B | 9.25 |
| Glaukos (GKOS) | United States | $5.571B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.243B | 22.23 |
| TransMedics (TMDX) | United States | $4.218B | 91.70 |
| PROCEPT BioRobotics (PRCT) | United States | $3.274B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.447B | 14.57 |
| Veracyte (VCYT) | United States | $2.256B | 31.66 |
| Elekta AB (EKTAY) | Sweden | $2.106B | 18.93 |
| Nihon Kohden (NHNKY) | Japan | $2.058B | 23.60 |
| Alphatec Holdings (ATEC) | United States | $1.896B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.567B | 0.00 |
| Artivion (AORT) | United States | $1.246B | 116.68 |
| Pulse Biosciences (PLSE) | United States | $1.148B | 0.00 |
| OPKO Health (OPK) | United States | $1.055B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.035B | 5.50 |
| SiBone (SIBN) | United States | $0.840B | 0.00 |
| Beta Bionics (BBNX) | United States | $0.687B | 0.00 |
| IRadimed (IRMD) | United States | $0.678B | 34.38 |
| RxSight (RXST) | United States | $0.675B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.627B | 13.70 |
| Delcath Systems (DCTH) | United States | $0.626B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.606B | 9.42 |
| NeuroPace (NPCE) | United States | $0.590B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.556B | 0.00 |
| AxoGen (AXGN) | United States | $0.527B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.468B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.467B | 12.43 |
| Treace Medical Concepts (TMCI) | United States | $0.421B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.386B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.358B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.306B | 0.00 |
| Neuronetics (STIM) | United States | $0.282B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.242B | 14.65 |
| Alpha Tau Medical (DRTS) | Israel | $0.229B | 0.00 |
| CVRx (CVRX) | United States | $0.182B | 0.00 |
| Accuray (ARAY) | United States | $0.179B | 0.00 |
| 908 Devices (MASS) | United States | $0.177B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.173B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.169B | 0.00 |
| Inogen (INGN) | United States | $0.169B | 0.00 |
| LENSAR (LNSR) | United States | $0.165B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.141B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.138B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.136B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.122B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.099B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.095B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.084B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.079B | 48.00 |
| EDAP TMS S.A (EDAP) | France | $0.071B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.066B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.056B | 17.08 |
| Hyperfine (HYPR) | United States | $0.048B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.044B | 0.00 |
| Envoy Medical (COCH) | United States | $0.037B | 0.00 |
| Spectral AI (MDAI) | United States | $0.034B | 0.00 |
| Precision Optics (POCI) | United States | $0.034B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.033B | 0.00 | |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.010B | 0.00 |
| Tenon Medical (TNON) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.007B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.001B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 17.06 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |